Clinical Cancer Research Joint Metastasis Research Society-AACR Conference on Metastasis Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jett, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jett, J. R.
Clinical Cancer Research Vol. 11, 4988s-4992s, July 1, 2005
© 2005 American Association for Cancer Research


Early Stage Lung Cancer: New Approaches to Evaluation and Treatment

Limitations of Screening for Lung Cancer with Low-Dose Spiral Computed Tomography

James R. Jett

Authors' Affiliation: Mayo Clinic, Rochester, Minnesota

Requests for reprints: James R. Jett, Thoracic Diseases and Medical Oncology, Mayo Clinic Rochester, 200 First Street Southwest, Rochester, MN 55905. Phone: 507-284-3764; Fax: 507-266-4372; E-mail: jett.james{at}mayo.edu.

Past lung cancer screening trials in the United States with chest X-ray and sputum cytology were not able to show any decrease in lung cancer mortality; however, these trials are over 20 years old. Recent follow-up of the Mayo Lung Project showed a better survival from lung cancer in the screened arm, but no difference in overall mortality, suggesting an overdiagnosis of nonfatal cancers. Recent reports of low radiation dose spiral computed tomography (CT) chest screening for lung cancer have shown that CT screening detects cancers at a smaller size than chest X-rays. To date, there have been no randomized trials of CT versus observation or chest radiographs for screening purposes. All data available thus far on CT screening are from phase II proof-of-principle trials. The major limitations of CT screening, discussed here, include (a) a high rate of nodule detection: over 50% of participants will have at least one noncalcified nodule; (b) resulting follow-up CT scans, associated with increased costs; (c) cost and morbidity of biopsy or resection of benign noncalcified nodule (20-25% of such procedures in several trials); and (d) a small, but difficult to quantify, risk of cancer associated with multiple follow-up CT scans.




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
M Bellomi, G Veronesi, C Rampinelli, S Ferretti, E De Fiori, and P Maisonneuve
Evolution of lung nodules <=5 mm detected with low-dose CT in asymptomatic smokers
Br. J. Radiol., September 1, 2007; 80(957): 708 - 712.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Allen-Auerbach, K. Yeom, J. Park, M. Phelps, and J. Czernin
Standard PET/CT of the Chest During Shallow Breathing Is Inadequate for Comprehensive Staging of Lung Cancer
J. Nucl. Med., February 1, 2006; 47(2): 298 - 301.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.